Michael Donnell - Cassava Sciences Independent Director
| SAVA Stock | USD 20.74 0.19 0.92% |
Director
Mr. Michael J. O Donnell, Esq., is Independent Director of the Company. He has served as a director since 1998. Mr. ODonnell was a member of the law firm of Morrison Foerster, LLP since January 2011. From 1993 to January 2011, Mr. ODonnell was a member of the law firm of Wilson Sonsini Goodrich Rosati, Professional Corporationrationration. Morrison Foerster, LLP is the Companys corporate counsel and provides legal services to the Company. Mr. ODonnell serves as corporate counsel to numerous public and private biopharmaceutical and life sciences companies
| Age | 59 |
| Address | 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731 |
| Phone | 512 501 2444 |
| Web | https://www.cassavasciences.com |
Cassava Sciences Management Efficiency
The company has return on total asset (ROA) of (0.3427) % which means that it has lost $0.3427 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5327) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences' management efficiency ratios could be used to measure how well Cassava Sciences manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.61. The current year's Return On Capital Employed is expected to grow to -0.73. At present, Cassava Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 7.9 M, whereas Total Assets are forecasted to decline to about 114.4 M.Similar Executives
| Found 9 records | DIRECTOR Age | ||
| Mark Brooks | Alimera Sciences | 50 | |
| John Snisarenko | Alimera Sciences | N/A | |
| Calvin Roberts | Alimera Sciences | 64 | |
| James Largent | Alimera Sciences | 67 | |
| Garheng Kong | Alimera Sciences | 42 | |
| Brian Halak | Alimera Sciences | 45 | |
| Mary Szela | Alimera Sciences | 55 | |
| Scott LLB | Lucy Scientific Discovery | 54 | |
| Peter Pizzo | Alimera Sciences | 50 | |
Management Performance
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.34 |
Cassava Sciences Leadership Team
Elected by the shareholders, the Cassava Sciences' board of directors comprises two types of representatives: Cassava Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cassava. The board's role is to monitor Cassava Sciences' management team and ensure that shareholders' interests are well served. Cassava Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cassava Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nadav Friedmann, Chief Medical and Operating Officer, Director | ||
| James MD, Chief Officer | ||
| Remi Barbier, Chairman of the Board and Presidentident, CEO | ||
| Michael Donnell, Independent Director | ||
| Michael Zamloot, Senior Operations | ||
| Michael PharmD, Senior Affairs | ||
| Robert Gussin, Independent Director | ||
| Saira Ramasastry, Independent Director | ||
| Lindsay Burns, Senior Neuroscience | ||
| Christopher Cook, Sr Counsel | ||
| Eric Schoen, Chief Officer | ||
| Nadav MD, Chief Director | ||
| Patrick Scannon, Independent Director | ||
| George Thornton, Senior Technology | ||
| Sanford Robertson, Independent Director |
Cassava Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cassava Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 775.35 M | ||||
| Shares Outstanding | 43.25 M | ||||
| Shares Owned By Insiders | 7.17 % | ||||
| Shares Owned By Institutions | 32.71 % | ||||
| Number Of Shares Shorted | 12.84 M | ||||
| Price To Book | 7.16 X | ||||
| Gross Profit | (68.03 M) | ||||
| EBITDA | (104.43 M) |
Currently Active Assets on Macroaxis
When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Cassava Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.32) | Return On Assets (0.34) | Return On Equity (0.53) |
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.